002872 Tiansheng Pharmaceutical Group
- 4.77
- -0.06-1.24%
Tiansheng Pharmaceutical Group News
ST Tiansheng: Progress announcement on matters relating to the implementation of other risk warnings for the company\'s stock trading
ST Tiansheng: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
ST Tiansheng: Announcement on the wholly-owned subsidiary aminophylline injection passing the generic drug consistency evaluation
ST Tiansheng: Legal Opinion of Bank of China Law Firm of Beijing on the 2024 First Extraordinary General Meeting of Shareholders of Tiansheng Pharmaceutical Group Co., Ltd.
ST Tiansheng: Progress announcement on matters relating to the implementation of other risk warnings for the company\'s stock trading
ST Tiansheng: Announcement on amending the “Articles of Association”
ST Tiansheng: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
ST Tiansheng: Progress announcement on matters relating to the implementation of other risk warnings for the company\'s stock trading
ST Tiansheng: Announcement on preparations for asset impairment for the semi-annual period of 2024
ST Tiansheng: Semi-annual non-operating capital usage and other related capital transactions summary table
ST Tiansheng: 2024 Semi-Annual Financial Report
Tiansheng Pharmaceutical Group: Announcement on the Progress of Other Risk Warnings for the Company's Stock Trading
Tiansheng Pharmaceutical Group: Announcement on the progress of receiving the "Criminal Judgment" and the litigation matters.
Tiansheng Pharmaceutical Group: Announcement on the Progress of Other Risk Warnings for the Company's Stock Trading
Tiansheng Pharmaceutical Group: Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Tiansheng Pharmaceutical Group: Announcement on the reply to the inquiry letter of the 2023 annual report of the Shenzhen Stock Exchange.
Tiansheng Pharmaceutical Group: Announcement regarding the company's application to banks to increase collateral for credit approval.
Tiansheng Pharmaceutical Group: Announcement on the Progress of Other Risk Warnings for the Company's Stock Trading
Tiansheng Pharmaceutical Group: Announcement Regarding the Delay in Responding to Shenzhen Stock Exchange's Inquiry Letter on Annual Reports.
Tiansheng Pharmaceutical Group: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Analysis
Price Target
No Data
No Data